SAN FRANCISCO--(BUSINESS WIRE)--Shennon Biotechnologies (“ShennonBio”), a biotech company using a proprietary single cell platform to create more effective immunotherapies, announced today the close ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Deepcell, a life science company pioneering AI-powered single cell classification and isolation for basic and translational research, today announced that it has ...
Clinical trials are an essential part of improving stroke care for patients, but each trial can also require years of planning and tens of millions of dollars from start to finish. Two University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results